Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli
- Resource Type
- Article
- Source
- In
Leukemia Research November 2016 50:95-103 - Subject
- Language
- ISSN
- 0145-2126